(Q34388601)

English

Etanercept in rheumatoid arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

Etanercept in rheumatoid arthritis (English)

1 reference

Europe PubMed Central

1 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

A Alldred

1

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

1 August 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

1 August 2017

2

1 reference

Europe PubMed Central

1 August 2017

7

1 reference

Europe PubMed Central

1 August 2017

1137-1148

1 reference

Europe PubMed Central

1 August 2017

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

Cytokines in autoimmunity

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

Lymphocyte in vitro Cytotoxicity: Lymphotoxins of Several Mammalian Species

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1137

21 January 2018

Identifiers

10.1517/14656566.2.7.1137

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34388601&oldid=2039668688"